| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |